ArticleFrontiers in oncology2025

Enhanced efficacy of immune checkpoint inhibitors combined locoregional therapy and tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma: A single - center retrospective study.

Junfeng Bu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.